Analysts Set Silicon Laboratories Inc. (NASDAQ:SLAB) Price Target at $136.20

Silicon Laboratories Inc. (NASDAQ:SLAB) has been given an average rating of “Moderate Buy” by the eleven analysts that are covering the stock, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $136.20.

Several research analysts recently commented on the stock. Stifel Nicolaus raised their price objective on shares of Silicon Laboratories from $135.00 to $145.00 and gave the stock a “buy” rating in a report on Monday, January 6th. Barclays lifted their price target on Silicon Laboratories from $75.00 to $120.00 and gave the company an “equal weight” rating in a research report on Friday, January 17th. Susquehanna assumed coverage on Silicon Laboratories in a research note on Tuesday, December 17th. They set a “neutral” rating and a $130.00 price objective on the stock. Benchmark restated a “buy” rating and issued a $160.00 target price on shares of Silicon Laboratories in a research note on Wednesday, March 12th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $150.00 target price on shares of Silicon Laboratories in a report on Wednesday, March 12th.

Silicon Laboratories Price Performance

NASDAQ:SLAB opened at $91.19 on Tuesday. The company has a market capitalization of $2.96 billion, a P/E ratio of -15.35 and a beta of 1.33. The business has a fifty day simple moving average of $132.76 and a two-hundred day simple moving average of $123.49. Silicon Laboratories has a 1 year low of $86.51 and a 1 year high of $160.00.

Silicon Laboratories (NASDAQ:SLAB) last announced its quarterly earnings data on Tuesday, February 4th. The semiconductor company reported ($0.11) earnings per share for the quarter, hitting the consensus estimate of ($0.11). The company had revenue of $166.25 million during the quarter, compared to analyst estimates of $166.09 million. Silicon Laboratories had a negative return on equity of 10.46% and a negative net margin of 32.69%. The firm’s revenue for the quarter was up 91.4% on a year-over-year basis. During the same quarter last year, the firm posted ($1.19) EPS. As a group, analysts anticipate that Silicon Laboratories will post -0.97 earnings per share for the current year.

Insider Activity

In related news, Director Navdeep S. Sooch sold 2,360 shares of the firm’s stock in a transaction that occurred on Wednesday, February 5th. The shares were sold at an average price of $149.00, for a total value of $351,640.00. Following the sale, the director now directly owns 400,567 shares of the company’s stock, valued at $59,684,483. This trade represents a 0.59 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director William G. Bock sold 1,000 shares of the business’s stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $149.43, for a total transaction of $149,430.00. Following the completion of the transaction, the director now directly owns 31,115 shares of the company’s stock, valued at approximately $4,649,514.45. This represents a 3.11 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 5,360 shares of company stock worth $782,610. 1.60% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Silicon Laboratories

Several hedge funds have recently added to or reduced their stakes in the company. Jones Financial Companies Lllp lifted its holdings in shares of Silicon Laboratories by 44.5% in the 4th quarter. Jones Financial Companies Lllp now owns 224 shares of the semiconductor company’s stock worth $28,000 after acquiring an additional 69 shares during the last quarter. Headlands Technologies LLC bought a new stake in Silicon Laboratories in the fourth quarter worth $70,000. Venturi Wealth Management LLC lifted its stake in Silicon Laboratories by 207.0% in the fourth quarter. Venturi Wealth Management LLC now owns 786 shares of the semiconductor company’s stock worth $98,000 after purchasing an additional 530 shares during the last quarter. Asset Management One Co. Ltd. purchased a new stake in Silicon Laboratories during the fourth quarter valued at about $117,000. Finally, KBC Group NV grew its stake in shares of Silicon Laboratories by 42.1% during the fourth quarter. KBC Group NV now owns 1,279 shares of the semiconductor company’s stock valued at $159,000 after buying an additional 379 shares during the last quarter.

Silicon Laboratories Company Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.